Leadership & Pay ·
Merck elects Paul J. Diaz to its Board of Directors, effective November 1
MRKMerck & Co., Inc.
Merck & Co., Inc. announced the election of Paul J. Diaz to its Board of Directors, effective November 1, 2026. Diaz, currently managing partner at Cressey & Company and former CEO of Myriad Genetics and Kindred Healthcare, will serve on the Audit and Research Committees. He will stand for shareholder election in May 2027, bringing healthcare industry expertise to the board which now consists of 14 members. Merck is a research-intensive biopharmaceutical company that develops medicines and vaccines.